These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey. Indra A; Schmid D; Huhulescu S; Simons E; Hell M; Stickler K; Allerberger F; Wien Klin Wochenschr; 2015 Aug; 127(15-16):587-93. PubMed ID: 26156942 [TBL] [Abstract][Full Text] [Related]
23. Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel. Miller-Roll T; Na'amnih W; Cohen D; Carmeli Y; Adler A Diagn Microbiol Infect Dis; 2016 Dec; 86(4):450-454. PubMed ID: 27638350 [TBL] [Abstract][Full Text] [Related]
24. Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution. Visconti V; Brunetti G; Cuomo MR; Giordano A; Raponi G J Infect Chemother; 2017 Nov; 23(11):763-768. PubMed ID: 28899610 [TBL] [Abstract][Full Text] [Related]
25. Public perception of Clostridium difficile. Collins JP; Roberts DM; Evans CF; De'Ath HD; Galland RB J Hosp Infect; 2009 May; 72(1):80-1. PubMed ID: 19282054 [No Abstract] [Full Text] [Related]
26. What is the true burden of Clostridium difficile disease? Wren MW; Coen PG; Shetty NP J Hosp Infect; 2007 Oct; 67(2):196-7. PubMed ID: 17884251 [No Abstract] [Full Text] [Related]
27. An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital. Graf K; Cohrs A; Gastmeier P; Kola A; Vonberg RP; Mattner F; Sohr D; Chaberny IF Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):543-5. PubMed ID: 18982365 [No Abstract] [Full Text] [Related]
33. Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027. Krutova M; Matejkova J; Tkadlec J; Nyc O Anaerobe; 2015 Dec; 36():88-90. PubMed ID: 26256807 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital. Bassetti M; Astilean A; Arzese A; Cimarosti R; Barbone F; Pecori D J Gastrointestin Liver Dis; 2014 Dec; 23(4):459-60. PubMed ID: 25532010 [No Abstract] [Full Text] [Related]
35. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Khanna S; Pardi DS Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014 [TBL] [Abstract][Full Text] [Related]
36. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Paltansing S; van den Berg RJ; Guseinova RA; Visser CE; van der Vorm ER; Kuijper EJ Clin Microbiol Infect; 2007 Nov; 13(11):1058-64. PubMed ID: 17922780 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile infection following hip fracture. Fenton P; Singh K; Cooper M J Hosp Infect; 2008 Apr; 68(4):376-7. PubMed ID: 18353494 [No Abstract] [Full Text] [Related]
38. Necessary but not sufficient: a comparison of surveillance definitions of Clostridium difficile-associated diarrhea. Fraser TG; Fatica C; Gordon SM Infect Control Hosp Epidemiol; 2009 Apr; 30(4):377-9. PubMed ID: 19228111 [TBL] [Abstract][Full Text] [Related]
39. New definitions will help, but cultures are critical for resolving unanswered questions about Clostridium difficile. Gerding DN Infect Control Hosp Epidemiol; 2007 Feb; 28(2):113-5. PubMed ID: 17265390 [No Abstract] [Full Text] [Related]
40. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Lambert PJ; Dyck M; Thompson LH; Hammond GW Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]